Australia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung...
Read moreThe European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is...
Read moreAllowing pharma companies to earn excessive profit is against the principles of morality and ethics, the National Consumer Commission has...
Read moreThe European Commission has granted orphan drug designation to Alexion Pharmaceuticals' Soliris (eculizumab), a terminal complement inhibitor, to treat patients...
Read moreBristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of...
Read moreThe US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly...
Read moreThe European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF). Kalydeco is for...
Read moreSwedish drugmaker Meda has agreed to acquire Italy-based Rottapharm Madaus for around €2.3bn as part of its strategy to boost...
Read morePfizer and Baxter have entered into a definitive agreement under which Pfizer will acquire Baxter's portfolio of marketed vaccines for...
Read moreThe courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
